Stable Angina
📧 Sign up to get email alerts when something new happens for Stable Angina.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2025-09-25Clinical Trial Update: Gene Therapy for the Treatment of Chronic Stable Angina [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial for chronic stable angina (myocardial ischemia) sponsored by Helixmith was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-03-13Clinical Trial Update: Efficacy of Ranolazine in Patients With Chronic Total Occlusions of Coronary Arteries [Phase 4]
Phase 4 trial evaluating ranolazine for myocardial ischemia in patients with chronic total occlusions was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-02-20Clinical Trial Update: COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials [Phase 4]
Phase 4 COSTA trials evaluating the COMBO-Stent in patients on chronic anticoagulation have been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2016-05-24Clinical Trial Update: A Study to Evaluate the Effects of Azilsartan on Coronary Artery Plaque in Essential Hypertensive Patients With Stable Angina and Dyslipidemia. [Phase 4]
A Phase 4 trial evaluating azilsartan on coronary artery plaque in patients with essential hypertension, stable angina, and dyslipidemia has…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: GS-6615 in Adults With Chronic Stable Angina and Coronary Artery Disease [Phase 2]
A Phase 2 trial of GS-6615 for chronic stable angina and coronary artery disease has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2011-01-13Clinical Trial Update: Capadenoson in Angina Pectoris [Phase 2]
A Phase 2 trial of Capadenoson for chronic stable angina has been withdrawn by sponsor Bayer.